127 related articles for article (PubMed ID: 3500051)
21. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children.
Winograd B; Lippens RJ; Oosterbaan MJ; Dirks MJ; Vree TB; van der Kleijn E
Eur J Clin Pharmacol; 1986; 30(2):231-8. PubMed ID: 3709652
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.
Tetef ML; Margolin KA; Doroshow JH; Akman S; Leong LA; Morgan RJ; Raschko JW; Slatkin N; Somlo G; Longmate JA; Carroll MI; Newman EM
Cancer Chemother Pharmacol; 2000; 46(1):19-26. PubMed ID: 10912573
[TBL] [Abstract][Full Text] [Related]
23. High dose methotrexate infusion with leucovorin rescue for treatment of ectopic pregnancy.
Larson DM; Tipping SJ; Mulligan GM; Johnson KK; Becker J
Wis Med J; 1995 Dec; 94(12):664-7. PubMed ID: 8571615
[TBL] [Abstract][Full Text] [Related]
24. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue.
Isacoff WH; Morrison PF; Aroesty J; Willis KL; Block JB; Lincoln TL
Cancer Treat Rep; 1977 Dec; 61(9):1665-74. PubMed ID: 304376
[TBL] [Abstract][Full Text] [Related]
27. Dose dependent methotrexate elimination following bolus intravenous injection.
Lawrence JR; Steele WH; Stuart JF; McNeill CA; McVie JG; Whiting B
Eur J Clin Pharmacol; 1980 May; 17(5):371-4. PubMed ID: 7418714
[TBL] [Abstract][Full Text] [Related]
28. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children.
Chatelut E; Roche H; Plusquellec Y; Peyrille F; De Biasi J; Pujol A; Canal P; Houin G
J Pharm Sci; 1991 Aug; 80(8):730-4. PubMed ID: 1791530
[TBL] [Abstract][Full Text] [Related]
30. High-dose methotrexate with a safe rescue program.
Decker DA; Edmonson JH; Gilchrist GS; Kovach JS; Offord JR; Taylor WF
Oncology; 1981; 38(5):262-4. PubMed ID: 6973732
[TBL] [Abstract][Full Text] [Related]
31. High-dose methotrexate with leucovorin rescue in patients with unresectable non-small cell carcinoma of the lung.
Brower M; Carney DN; Ihde DC; Eddy J; Bunn PA; Cohen MH; Pelsor FR; Matthews MJ; Minna JD
Cancer; 1983 Nov; 52(10):1778-82. PubMed ID: 6605186
[TBL] [Abstract][Full Text] [Related]
32. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
[TBL] [Abstract][Full Text] [Related]
34. High-dose methotrexate: pharmacokinetics in children and young adults.
Raude E; Oellerich M; Weinel P; Freund M; Schrappe M; Riehm H; Poliwoda H
Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):364-70. PubMed ID: 3209285
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate in the plasma and cerebrospinal fluid of children treated with intermediate dose methotrexate.
Rechnitzer C; Scheibel E; Hendel J
Acta Paediatr Scand; 1981 Sep; 70(5):615-8. PubMed ID: 6976674
[TBL] [Abstract][Full Text] [Related]
37. Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats.
Fuksa L; Brcakova E; Cermanova J; Hroch M; Chladek J; Kolouchova G; Malakova J; Martinkova J; Staud F; Micuda S
Biopharm Drug Dispos; 2008 Jul; 29(5):289-99. PubMed ID: 18548509
[TBL] [Abstract][Full Text] [Related]
38. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
39. [Investigation on individualized adjustment of target range of high-dose methotrexate].
Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
[TBL] [Abstract][Full Text] [Related]
40. The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis.
Seideman P; Beck O; Eksborg S; Wennberg M
Br J Clin Pharmacol; 1993 Apr; 35(4):409-12. PubMed ID: 8485020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
